Novo Nordisk A/S maintains a Buy rating, driven by strong Wegovy pill uptake and a robust GLP-1 franchise despite competitive and pricing headwinds. NVO's oral Wegovy has rapidly captured 90% of the US oral obesity market, with over 5 million prescriptions since launch and accelerating growth momentum. Upcoming CagriSema approval and differentiated pipeline position NVO to compete effectively with Lilly, especially as next-generation injectables approach.

GAP heads into Q2 with expected sales and earnings declines as Old Navy softness and Athleta's rebuild offset momentum at the Gap brand.

AppFolio's annual conference delivers the strategies that separate market leaders from the rest. SANTA BARBARA, Calif.

WESTFORD, Mass.--(BUSINESS WIRE)--NETSCOUT® (NASDAQ: NTCT), a leading provider of observability, AIOps, cybersecurity, and DDoS attack protection solutions, today announced enhancements to its Arbor Edge Defense (AED) solution that helps enterprises maintain the availability of revenue-generating and mission-critical applications against sophisticated DDoS attacks that evade or bypass content delivery network (CDN) DDoS defenses. The enhancements identify malicious sources concealed behind shar.

Home Depot's comp acceleration points to share shift and mix advantage rather than an industry-wide recovery.

SAN FRANCISCO--(BUSINESS WIRE)--DoorDash, Inc. (Nasdaq: DASH), a global leader in local commerce, and Gap, a global apparel and accessories retailer, today announced a partnership that makes it easier than ever for consumers to shop the styles they love on-demand, just in time for back-to-school. Consumers nationwide can now get their favorites for the whole family, from kids' first-day fits to everyday fall essentials, delivered to their doors through DoorDash. Gap Factory is also joining the.

SELLAS Life Sciences Group is a high-conviction buy ahead of the pivotal Phase 3 REGAL trial readout for GPS in AML. The unusually long REGAL trial timeline suggests GPS may be delivering a meaningful survival benefit in a high-unmet-need AML population. SLS is well-funded into 2027, with $138.3 million in cash and targeted spending aligned to upcoming binary catalysts.

Gap's turnaround effort may be progressing at its namesake stores, but worries about weakness at Old Navy have one group of analysts downgrading the stock.

SAN FRANCISCO, Aug. 12, 2026 /PRNewswire/ --  Gap Inc . (NYSE: GAP) today announced that its board of directors has authorized a third quarter fiscal year 2026 dividend of $0.175 per share, payable on or after October 28, 2026, to shareholders of record at the close of business on October 7, 2026.

Gap Inc (NYSE:GPS) shares fell 3.8% on Wednesday after Jefferies downgraded the retailer to "Hold" from "Buy," citing growing concerns over softening trends at its Old Navy division. The brokerage cut its price target to $23, rolling forward a roughly 9x price-to-earnings multiple on its fiscal 2028 earnings estimate of $2.56 per share.